HOME >> MEDICINE >> NEWS
Research shows survival benefit for leukemia patients treated with arsenic trioxide

WINSTON-SALEM, N.C. -- Through participation in a government-sponsored multi-year study, researchers at the Comprehensive Cancer Center at Wake Forest University have helped confirm that arsenic trioxide marketed as Trisenox significantly improves patient survival when coupled with standard chemotherapy treatment in newly diagnosed patients with acute promyelocytic leukemia, or APL.

Bayard Powell, M.D., principal investigator of the study and professor and section head of Hematology and Oncology at Wake Forest University Baptist Medical Center, presented the findings today at the annual meeting of the American Society of Clinical Oncology (ASCO).

Nearly 600 patients in the U.S. and Canada participated in the phase III study over a six-year period from June 1999 through March 2005. The study was sponsored by the National Cancer Institute (NCI) and led by one of its cooperative groups, the Cancer and Leukemia Group B (CALGB). The Comprehensive Cancer Center at Wake Forest University is a member of CALGB.

Patients receiving the arsenic trioxide had a significantly higher likelihood of remaining disease-free, with longer survival than those receiving standard chemotherapy alone, said Powell. The results are so compelling that we recommend use of arsenic trioxide in first-line treatment of APL.

APL is a cancer of the bone marrow in which cancerous cells eventually crowd out the healthy blood cells needed for the body to function normally.

Karen Shelton, a 58 year-old nurse from Kannapolis, was diagnosed with APL in 2001. Ms. Shelton was offered the opportunity to participate in the arsenic trioxide trial. I was eager to take part in the study. Even if it didnt help me, it might help others, she said. She was one of 26 patients enrolled through Wake Forest Baptist.

In remission for nearly six years, Shelton is an advocate of the therapy. I truly believe chemotherapy put me in remission, but the arseni
'"/>

Contact: Jonnie Rohrer
jrohrer@wfubmc.edu
336-716-6972
Wake Forest University Baptist Medical Center
4-Jun-2007


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. RAND presents first Victor Fuchs Research Award to economists at Carnegie Mellon University
5. Wesley Research Institute study targets pharmacists to help diabetes sufferers
6. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
7. Research probes seniors plans for end-of-life care
8. DFG approves 11 new Collaborative Research Centers
9. Researchers call for investigation into links between khat use and psychiatric disorders
10. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
11. Researcher says few families report safe firearm storage

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 10, 2019 , ... ... UN Chamber Music Society at the United Nations Staff Recreation Council in support ... is to provide complementary services including music, art, massage, and pet therapies to ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, ... partnered with MD101, a regulatory consulting company that serves the medical industry. The ... servicing companies in the medical device and healthcare industries. Based in France, they ...
(Date:1/10/2019)... ... January 10, 2019 , ... GoGreen Hemp is excited ... Face Mask. CBD, or Cannabidiol, is one of many cannabinoids found in the ... influences receptors that are naturally present in the body to produce desirable effects ...
(Date:1/8/2019)... ... ... West 10th Dental in New York, NY is pleased to announce the ... Sengos, founder of West 10th Dental, "We want our patients to know that we ... keeping up with the latest in technology as dentistry changes, and by making ourselves ...
(Date:1/8/2019)... ... January 08, 2019 , ... ... announced that they now have Norepinephrine in their patent-pending vial-based configuration, Snap-N-Go®, ... (in concentrations that are not commercially available) deliver a precise dose when ...
Breaking Medicine News(10 mins):
(Date:1/10/2019)... ... January 10, 2019 , ... ... the new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art family of ... systems, enabling Mindray to continue its unwavering commitment to perioperative care. , ...
(Date:1/10/2019)... ... January 10, 2019 , ... ... network continues to rapidly expand under the leadership of Dominic Hyde, vice president ... performance, cost effective temperature controlled shipper rental program allowing organizations to choose the ...
(Date:1/8/2019)... ... January 08, 2019 , ... ... designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Jaeger ... and demonstrated a commitment to exemplary care for men suffering from symptoms associated ...
Breaking Medicine Technology:
Cached News: